Publications

The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study.

CLARK, RA; Mukandavire, C; Portnoy, A; WEERASURIYA, CK; Deol, A; SCARPONI, D; Iskauskas, A; Bakker, R; Quaife, M; Malhotra, S; Gebreselassie, N; Zignol, M; Hutubessy, RC W; Giersing, B; JIT, M; Harris, RC; Menzies, NA; WHITE, RG;

2023

The Lancet. Global health, (2023).11 4 10.1016/s2214-109x(23)00045-1.

The impact of alternative delivery strategies for novel tuberculosis vaccines in low- and middle-income countries: a modelling study.

CLARK, R; Mukandavire, C; Portnoy, A; WEERASURIYA, C; Deol, A; SCARPONI, D; Iskauskas, A; Bakker, R; Quaife, M; Malhotra, S; Gebreselassie, N; Zignol, M; Hutubessy, RC W; Giersing, B; JIT, M; Harris, R; Menzies, N; WHITE, R;

2022

medRxiv (2022). 10.1101/2022.04.16.22273762.

Prevalence of malaria and helminth infections in rural communities in northern Sierra Leone, a baseline study to inform Ebola vaccine study protocols. S1 Data.

Baiden, F; FLECK, S; Leigh, B; Ayieko, P; Tindanbil, D; Otieno, T; Lawal, B; Tehtor, M; Rogers, M; Odeny, L; Hodges, MH; Sonnie, M; Samai, M; Ishola, D; Lowe, B; WATSON-JONES, D; GREENWOOD, B;

2022

, PLOS ONE (2022).

Human papillomavirus vaccine communication materials for young people in English-speaking countries: A content analysis.

Fisher, H; CHANTLER, T; MOUNIER-JACK, S; Audrey, S;

2022

Health education journal, (2022).81 5 10.1177/00178969221092135.

Effectiveness of case-area targeted interventions including vaccination on the control of epidemic cholera: protocol for a prospective observational study.

RATNAYAKE, R; Peyraud, N; Ciglenecki, I; Gignoux, E; Lightowler, M; Azman, AS; Gakima, P; Ouamba, JP; Sagara, JA; Ndombe, R; Mimbu, N; Ascorra, A; Epicentre and MSF CATI Working Group,; Welo, PO; Mukamba Musenga, E; Miwanda, B; Boum, Y; CHECCHI, F; EDMUNDS, WJ; Luquero, F; Porten, K; Finger, F;

2022

BMJ Open, (2022).12 7 10.1136/bmjopen-2022-061206.

Cost-effectiveness of routine adolescent vaccination with an M72/AS01E-like tuberculosis vaccine in South Africa and India.

Harris, RC; QUAIFE, M; WEERASURIYA, C; Gomez, GB; SUMNER, T; BOZZANI, F; WHITE, RG;

2022

Nature Communications, (2022).13 1 10.1038/s41467-022-28234-7.

In Elimination Settings, Measles Antibodies Wane After Vaccination but Not After Infection: A Systematic Review and Meta-Analysis.

Bolotin, S; Osman, S; Hughes, SL; Ariyarajah, A; Tricco, AC; Khan, S; Li, L; Johnson, C; Friedman, L; Gul, N; Jardine, R; Faulkner, M; Hahné, SJ M; Heffernan, JM; Dabbagh, A; Rota, PA; Severini, A; JIT, M; Durrheim, DN; Orenstein, WA; Moss, WJ; FUNK, S; Turner, N; Schluter, W; Jawad, JS; ... Crowcroft, NS.

2022

The Journal of infectious diseases, (2022).226 7 10.1093/infdis/jiac039.

Prevalence of malaria and helminth infections in rural communities in northern Sierra Leone, a baseline study to inform Ebola vaccine study protocols.

Baiden, F; FLECK, S; Leigh, B; Ayieko, P; Tindanbil, D; Otieno, T; Lawal, B; Tehtor, M; Rogers, M; Odeny, L; Hodges, MH; Sonnie, M; Samai, M; Ishola, D; Lowe, B; WATSON-JONES, D; GREENWOOD, B;

2022

PLoS One, (2022).17 7 10.1371/journal.pone.0270968.

COVID-19 in Europe: new challenges for addressing vaccine hesitancy.

KARAFILLAKIS, E; Van Damme, P; Hendrickx, G; LARSON, HJ;

2022

LANCET, (2022).399 10326 10.1016/S0140-6736(22)00150-7.

Exploring the subnational inequality and heterogeneity of the impact of routine measles immunisation in Africa.

Echeverria-Londono, S; Hartner, A-M; Li, X; Roth, J; Portnoy, A; SBARRA, AN; ABBAS, K; Ferrari, M; FU, H; JIT, M; Ferguson, NM; Gaythorpe, KA M;

2022

Vaccine, (2022).40 47 10.1016/j.vaccine.2022.09.049.